Search all trials

Find therapies in clinical trials near you – page 16

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Parkinson's disease

Not recruiting

Investigational

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Prasinezumab

Contact Research Centre

Neoplasm

Not recruiting

InvestigationalNo placebo

Study of RVU120 for Patients with Advanced Solid Tumors After Standard Treatments Have Failed

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride

Contact Research Centre

Multiple sclerosis relapse

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Ofatumumab

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Teclistamab

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Itepekimab

Contact Research Centre

Breast cancer+7

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Hypercholesterolaemia

Not recruiting

InvestigationalNo placebo

Study on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Enlicitide Chloride

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Ramucirumab and Erlotinib for Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Erlotinib

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Alopecia areata

Not recruiting

Investigational

Study of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Idiopathic pulmonary fibrosis+1

Not recruiting

Investigational

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Bi 1839100

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Find therapies in clinical trials near you – page 16

296 trials match your criteria

Parkinson's disease

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Neoplasm

Study of RVU120 for Patients with Advanced Solid Tumors After Standard Treatments Have Failed

Multiple sclerosis relapse

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Plasma cell myeloma refractory

Study of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Chronic obstructive pulmonary disease

Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Breast cancer+7

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Hypercholesterolaemia

Study on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol

Non-small cell lung cancer

Study of Ramucirumab and Erlotinib for Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer

Multiple sclerosis

Study on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Alopecia areata

Study of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)

Idiopathic pulmonary fibrosis+1

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Plasma cell myeloma

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.